| Mrs Christine Marie Nett, LCSW | |
|
2801 Calumet Dr, Sheboygan, WI 53083 | |
| (920) 451-6908 | |
| (920) 458-6439 |
| Full Name | Mrs Christine Marie Nett |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 35 Years |
| Location | 2801 Calumet Dr, Sheboygan, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043322993 | NPI | - | NPPES |
| 39292200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1204 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nett Work Family Counseling Llc | 5597849604 | 5 |
News Archive
Less than one third of healthcare workers have themselves vaccinated against classic influenza. This reluctance is astounding, firstly because vaccination against influenza viruses is considered safe and effective and secondly because it has been proved to prevent nosocomial transmission of disease to patients-provided at least 50% of employees have been vaccinated.
UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.
The Aging Brain Care Medical Home, a novel brain-focused population health management program implemented in the homes of older adults, lowered depression severity by more than 50 percent over six months according to a new study from the Regenstrief Institute, Indiana University Center for Aging Research, IU Center for Health Innovation and Implementation Science, and Eskenazi Health.
Cognitive remediation, an evidence-based, recovery-oriented behavioral intervention for patients with mental illness, can feasibly be implemented in large systems of care, according to researchers at the New York State Psychiatric Institute and Columbia University Irving Medical Center.
The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.
› Verified 5 days ago
| Entity Name | Nett Work Family Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053406066 PECOS PAC ID: 5597849604 Enrollment ID: O20080228000182 |
News Archive
Less than one third of healthcare workers have themselves vaccinated against classic influenza. This reluctance is astounding, firstly because vaccination against influenza viruses is considered safe and effective and secondly because it has been proved to prevent nosocomial transmission of disease to patients-provided at least 50% of employees have been vaccinated.
UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.
The Aging Brain Care Medical Home, a novel brain-focused population health management program implemented in the homes of older adults, lowered depression severity by more than 50 percent over six months according to a new study from the Regenstrief Institute, Indiana University Center for Aging Research, IU Center for Health Innovation and Implementation Science, and Eskenazi Health.
Cognitive remediation, an evidence-based, recovery-oriented behavioral intervention for patients with mental illness, can feasibly be implemented in large systems of care, according to researchers at the New York State Psychiatric Institute and Columbia University Irving Medical Center.
The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Christine Marie Nett, LCSW 2801 Calumet Dr, Sheboygan, WI 53083 Ph: (920) 451-6908 | Mrs Christine Marie Nett, LCSW 2801 Calumet Dr, Sheboygan, WI 53083 Ph: (920) 451-6908 |
News Archive
Less than one third of healthcare workers have themselves vaccinated against classic influenza. This reluctance is astounding, firstly because vaccination against influenza viruses is considered safe and effective and secondly because it has been proved to prevent nosocomial transmission of disease to patients-provided at least 50% of employees have been vaccinated.
UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.
The Aging Brain Care Medical Home, a novel brain-focused population health management program implemented in the homes of older adults, lowered depression severity by more than 50 percent over six months according to a new study from the Regenstrief Institute, Indiana University Center for Aging Research, IU Center for Health Innovation and Implementation Science, and Eskenazi Health.
Cognitive remediation, an evidence-based, recovery-oriented behavioral intervention for patients with mental illness, can feasibly be implemented in large systems of care, according to researchers at the New York State Psychiatric Institute and Columbia University Irving Medical Center.
The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.
› Verified 5 days ago
Nancy Ellen Koene, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2801 Calumet Dr, Sheboygan, WI 53083 Phone: 920-451-6908 | |
Erin Meyer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1721 Saemann Ave, Sheboygan, WI 53081 Phone: 920-783-6633 Fax: 920-783-6392 | |
Sarah L Casper, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2414 Kohler Memorial Dr, Sheboygan, WI 53081 Phone: 920-457-4461 | |
Jokasha E Klest, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 314 Niagara Ave, Sheboygan, WI 53081 Phone: 920-451-8667 | |
Mr. John Anthony Daane, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2414 Kohler Memorial Dr, Sheboygan, WI 53081 Phone: 920-457-4461 Fax: 920-459-1483 | |
Mary Kay Howie, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 5934 S Business Dr, Sheboygan, WI 53081 Phone: 920-459-9277 Fax: 920-459-7920 |